**Outlook:**BioCardia Inc. Warrant is assigned short-term Ba1 & long-term B2 estimated rating.

**AUC Score :**

**Short-Term Revised**

^{1}:**Dominant Strategy :**Hold

**Time series to forecast n:** for

^{2}

**Methodology :**Modular Neural Network (Market Volatility Analysis)

**Hypothesis Testing :**Statistical Hypothesis Testing

**Surveillance :**Major exchange and OTC

^{1}The accuracy of the model is being monitored on a regular basis.(15-minute period)

^{2}Time series is updated based on short-term trends.

## Summary

BioCardia Inc. Warrant prediction model is evaluated with Modular Neural Network (Market Volatility Analysis) and Statistical Hypothesis Testing^{1,2,3,4}and it is concluded that the BCDAW stock is predictable in the short/long term. Modular neural networks (MNNs) are a type of artificial neural network that can be used for market volatility analysis. MNNs are made up of multiple smaller neural networks, called modules. Each module is responsible for learning a specific task, such as identifying patterns in data or predicting future price movements. The modules are then combined to form a single neural network that can perform multiple tasks.In the context of market volatility analysis, MNNs can be used to identify patterns in market data that suggest that the market is becoming more or less volatile. This information can then be used to make predictions about future price movements.

^{5}

**According to price forecasts for 1 Year period, the dominant strategy among neural network is: Hold**

## Key Points

- Modular Neural Network (Market Volatility Analysis) for BCDAW stock price prediction process.
- Statistical Hypothesis Testing
- Dominated Move
- Trading Signals
- Decision Making

## BCDAW Stock Price Forecast

We consider BioCardia Inc. Warrant Decision Process with Modular Neural Network (Market Volatility Analysis) where A is the set of discrete actions of BCDAW stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.^{1,2,3,4}

**Sample Set:**Neural Network

**Stock/Index:**BCDAW BioCardia Inc. Warrant

**Time series to forecast:**1 Year

**According to price forecasts, the dominant strategy among neural network is: Hold**

^{6,7}= $\begin{array}{cccc}{p}_{\mathrm{a}1}& {p}_{\mathrm{a}2}& \dots & {p}_{1n}\\ & \vdots \\ {p}_{j1}& {p}_{j2}& \dots & {p}_{jn}\\ & \vdots \\ {p}_{k1}& {p}_{k2}& \dots & {p}_{kn}\\ & \vdots \\ {p}_{n1}& {p}_{n2}& \dots & {p}_{nn}\end{array}$ X R(Modular Neural Network (Market Volatility Analysis)) X S(n):→ 1 Year $\overrightarrow{R}=\left({r}_{1},{r}_{2},{r}_{3}\right)$

n:Time series to forecast

p:Price signals of BCDAW stock

j:Nash equilibria (Neural Network)

k:Dominated move of BCDAW stock holders

a:Best response for BCDAW target price

Modular neural networks (MNNs) are a type of artificial neural network that can be used for market volatility analysis. MNNs are made up of multiple smaller neural networks, called modules. Each module is responsible for learning a specific task, such as identifying patterns in data or predicting future price movements. The modules are then combined to form a single neural network that can perform multiple tasks.In the context of market volatility analysis, MNNs can be used to identify patterns in market data that suggest that the market is becoming more or less volatile. This information can then be used to make predictions about future price movements.

^{5}Statistical hypothesis testing is a process used to determine whether there is enough evidence to support a claim about a population based on a sample. The process involves making two hypotheses, a null hypothesis and an alternative hypothesis, and then collecting data and using statistical tests to determine which hypothesis is more likely to be true. The null hypothesis is the statement that there is no difference between the population and the sample. The alternative hypothesis is the statement that there is a difference between the population and the sample. The statistical test is used to calculate a p-value, which is the probability of obtaining the observed data or more extreme data if the null hypothesis is true. A p-value of less than 0.05 is typically considered to be statistically significant, which means that there is less than a 5% chance of obtaining the observed data or more extreme data if the null hypothesis is true.

^{6,7}

For further technical information as per how our model work we invite you to visit the article below:

### BCDAW Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

**X axis: *Likelihood%** (The higher the percentage value, the more likely the event will occur.)

**Y axis: *Potential Impact%** (The higher the percentage value, the more likely the price will deviate.)

**Z axis (Grey to Black): *Technical Analysis%**

### Financial Data Adjustments for Modular Neural Network (Market Volatility Analysis) based BCDAW Stock Prediction Model

- The requirements in paragraphs 6.8.4–6.8.8 may cease to apply at different times. Therefore, in applying paragraph 6.9.1, an entity may be required to amend the formal designation of its hedging relationships at different times, or may be required to amend the formal designation of a hedging relationship more than once. When, and only when, such a change is made to the hedge designation, an entity shall apply paragraphs 6.9.7–6.9.12 as applicable. An entity also shall apply paragraph 6.5.8 (for a fair value hedge) or paragraph 6.5.11 (for a cash flow hedge) to account for any changes in the fair value of the hedged item or the hedging instrument.
- For the purposes of measuring expected credit losses, the estimate of expected cash shortfalls shall reflect the cash flows expected from collateral and other credit enhancements that are part of the contractual terms and are not recognised separately by the entity. The estimate of expected cash shortfalls on a collateralised financial instrument reflects the amount and timing of cash flows that are expected from foreclosure on the collateral less the costs of obtaining and selling the collateral, irrespective of whether foreclosure is probable (ie the estimate of expected cash flows considers the probability of a foreclosure and the cash flows that would result from it). Consequently, any cash flows that are expected from the realisation of the collateral beyond the contractual maturity of the contract should be included in this analysis. Any collateral obtained as a result of foreclosure is not recognised as an asset that is separate from the collateralised financial instrument unless it meets the relevant recognition criteria for an asset in this or other Standards.
- When designating a group of items as the hedged item, or a combination of financial instruments as the hedging instrument, an entity shall prospectively cease applying paragraphs 6.8.4–6.8.6 to an individual item or financial instrument in accordance with paragraphs 6.8.9, 6.8.10, or 6.8.11, as relevant, when the uncertainty arising from interest rate benchmark reform is no longer present with respect to the hedged risk and/or the timing and the amount of the interest rate benchmark-based cash flows of that item or financial instrument.
- The requirement that an economic relationship exists means that the hedging instrument and the hedged item have values that generally move in the opposite direction because of the same risk, which is the hedged risk. Hence, there must be an expectation that the value of the hedging instrument and the value of the hedged item will systematically change in response to movements in either the same underlying or underlyings that are economically related in such a way that they respond in a similar way to the risk that is being hedged (for example, Brent and WTI crude oil).

*International Financial Reporting Standards (IFRS) adjustment process involves reviewing the company's financial statements and identifying any differences between the company's current accounting practices and the requirements of the IFRS. If there are any such differences, neural network makes adjustments to financial statements to bring them into compliance with the IFRS.

### BCDAW BioCardia Inc. Warrant Financial Analysis*

Rating | Short-Term | Long-Term Senior |
---|---|---|

Outlook* | Ba1 | B2 |

Income Statement | B1 | Caa2 |

Balance Sheet | Baa2 | Caa2 |

Leverage Ratios | Ba1 | B3 |

Cash Flow | B1 | Caa2 |

Rates of Return and Profitability | Baa2 | Baa2 |

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.

How does neural network examine financial reports and understand financial state of the company?

## References

- H. Khalil and J. Grizzle. Nonlinear systems, volume 3. Prentice hall Upper Saddle River, 2002.
- R. Rockafellar and S. Uryasev. Optimization of conditional value-at-risk. Journal of Risk, 2:21–42, 2000.
- Li L, Chu W, Langford J, Moon T, Wang X. 2012. An unbiased offline evaluation of contextual bandit algo- rithms with generalized linear models. In Proceedings of 4th ACM International Conference on Web Search and Data Mining, pp. 297–306. New York: ACM
- Chernozhukov V, Newey W, Robins J. 2018c. Double/de-biased machine learning using regularized Riesz representers. arXiv:1802.08667 [stat.ML]
- H. Khalil and J. Grizzle. Nonlinear systems, volume 3. Prentice hall Upper Saddle River, 2002.
- Y. Chow and M. Ghavamzadeh. Algorithms for CVaR optimization in MDPs. In Advances in Neural Infor- mation Processing Systems, pages 3509–3517, 2014.
- E. Altman. Constrained Markov decision processes, volume 7. CRC Press, 1999

## Frequently Asked Questions

Q: Is BCDAW stock expected to rise?A: BCDAW stock prediction model is evaluated with Modular Neural Network (Market Volatility Analysis) and Statistical Hypothesis Testing and it is concluded that dominant strategy for BCDAW stock is Hold

Q: Is BCDAW stock a buy or sell?

A: The dominant strategy among neural network is to Hold BCDAW Stock.

Q: Is BioCardia Inc. Warrant stock a good investment?

A: The consensus rating for BioCardia Inc. Warrant is Hold and is assigned short-term Ba1 & long-term B2 estimated rating.

Q: What is the consensus rating of BCDAW stock?

A: The consensus rating for BCDAW is Hold.

Q: What is the forecast for BCDAW stock?

A: BCDAW target price forecast: Hold

- Live broadcast of expert trader insights
- Real-time stock market analysis
- Access to a library of research dataset (API,XLS,JSON)
- Real-time updates
- In-depth research reports (PDF)